2-(3-Nitropyridin-2-yl)acetic acid | 1214374-87-4

• 分子结构分类: 有机化合物 - 有机1,3-偶极化合物 - 烯丙基型1,3-偶极有机化合物
• 英文名称: 2-(3-Nitropyridin-2-yl)acetic acid
• CAS: 1214374-87-4
• 化学式: C7H6N2O4
• 分子量: 182.13
• InChiKey: YCDCTYHGROLWQR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  96
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• HETEROCYCLIC COMPOUND
  申请人：TAKEDA PHARMACEUTICAL COMPANY LIMITED

  公开号：US20160159808A1

  公开（公告）日：2016-06-09

  A compound represented by the formula (I): wherein each symbol is as described in the SPECIFICATION, or a salt thereof has a PDE2A inhibitory action, and is useful as a prophylactic or therapeutic drug for schizophrenia, Alzheimer's disease and the like.

  化合物的化学式为(I)：其中每个符号如规范中所述，或其盐具有PDE2A抑制作用，并且可用作精神分裂症、阿尔茨海默病等疾病的预防或治疗药物。
• Thrombin inhibitors
  申请人：——

  公开号：US20030225131A1

  公开（公告）日：2003-12-04

  Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: 1 or a pharmaceutically acceptable salt thereof.

  本发明的化合物在抑制凝血酶和相关血栓闭塞方面具有以下结构：1或其药用可接受的盐。
• CHEMICAL COMPOUNDS
  申请人：SmithKline Beecham Corporation

  公开号：EP1430053A1

  公开（公告）日：2004-06-23
• [EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSES CHIMIQUES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2003027111A1

  公开（公告）日：2003-04-03

  The present invention is related to aza-oxindole derivatives formula (I), wherein X is N and Z is CHio; X is CH and Z is Ni, compositions containing the same, and methods of use and manufacture of the same. Such compounds generally are useful pharmacologically as agents in those disease states alleviated by the alteration of mitogen activated signaling pathways in general, and in particular in the inhibition or antagonism of protein kinases, which pathologically involve aberrant cellular proliferation. Such disease states include tumor growth, restenosis, atherosclerosis, pain and thrombosis. In particular, the present invention relates to a series of substituted oxindole compounds, which exhibit Trk family protein tyrosine kinase inhibition, and which are useful in cancer therapy and chronic pain indications.